CRISPR-Edited T Cells Used in Cancer Patients for the First Time in the US
CRISPR-Edited T Cells Used in Cancer Patients for the First Time in the US
The initial findings from a small clinical trial of patients with multiple myeloma or sarcoma suggest that gene-edited immunotherapy is safe.
CRISPR-Edited T Cells Used in Cancer Patients for the First Time in the US
CRISPR-Edited T Cells Used in Cancer Patients for the First Time in the US

The initial findings from a small clinical trial of patients with multiple myeloma or sarcoma suggest that gene-edited immunotherapy is safe.

The initial findings from a small clinical trial of patients with multiple myeloma or sarcoma suggest that gene-edited immunotherapy is safe.

myeloma
Genetic Sequencing Uncovers New Options for Multiple Myeloma Patients
Genetic Sequencing Uncovers New Options for Multiple Myeloma Patients
Shawna Williams | Nov 1, 2018
A small pilot study suggests the approach can identify effective treatments already approved for other cancers.
CRISPR Trial for Cancer Patients Proposed
CRISPR Trial for Cancer Patients Proposed
Katarina Zimmer | Jan 19, 2018
US researchers could become the first outside China to use the gene-editing technique in the clinic.